{"id":"W2801738355","doi":"10.1016/j.healthpol.2018.04.008","title":"An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?","year":2018,"lang":"en","type":"article","venue":"Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"Bristol-Myers Squibb","keywords":"Nivolumab; Docetaxel; Cost–benefit analysis; Cost effectiveness; Medicine; Quality of life (healthcare); Quality-adjusted life year; Cost-effectiveness analysis; Productivity; Perspective (graphical); Actuarial science; Oncology; Economics; Cancer; Internal medicine; Nursing; Economic growth; Risk analysis (engineering); Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003397342,0.0005802089,0.0004828865,0.001076615,0.002814074,0.001490571,0.001389772,0.002058785,0.003631162],"category_scores_gemma":[0.009835844,0.0002806452,0.001417661,0.001142287,0.001075918,0.0004476586,0.0008247257,0.001170672,0.0001251245],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03345506,"about_ca_system_score_gemma":0.02176244,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6129198,"about_ca_topic_score_gemma":0.6758313,"domain_scores_codex":[0.9975076,0.001111166,0.00009891709,0.0001828301,0.0004824185,0.0006170392],"domain_scores_gemma":[0.9922572,0.004879914,0.0006556921,0.0001823992,0.001208148,0.0008165747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009337618,0.01074934,0.4556416,0.003932548,0.00181052,0.09261037,0.01040932,0.1962063,0.006143123,0.04300679,0.02825034,0.1419023],"study_design_scores_gemma":[0.004513275,0.01302395,0.4213609,0.002873464,0.002357213,0.0387869,0.06429303,0.3681895,0.008390632,0.01245953,0.06315035,0.0006012942],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786891,0.001860188,0.002812044,0.003348374,0.00004520897,0.001414108,0.001217978,0.0000150485,0.01059799],"genre_scores_gemma":[0.9933128,0.000624561,0.0041485,0.0002423094,0.00002340696,0.0001904718,0.0002572975,0.000005442309,0.001195261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9665449,"threshold_uncertainty_score":0.7787195,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.195842062697321,"score_gpt":0.4642715330403461,"score_spread":0.2684294703430251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}